SEC Form 4 reporting owner

Harmon Cyrus

Harmon Cyrus has filed 6 Form 4 transactions reported between December 22, 2025 and July 24, 2026, as a reporting owner of Olema Pharmaceuticals, Inc..

Name as filed: Harmon Cyrus

Open-market buys, 24 mo
None
reported
Open-market sales, 24 mo
$744K
5 lines
Companies
1
with Form 4 filings
Latest transaction
Jul 24, 2026
transaction date

Roles and reported holdings

  • OLMAOlema Pharmaceuticals, Inc.
    Dec 22, 2025 – Jul 24, 2026

    Reporting owner

    Held directly702,770 sh as of Jul 24, 2026 · Form 4

    24 months: $744K sold

Transaction history

All 6 reported transactions, newest first. Every row links to the Form 4 on SEC EDGAR.

DateCompanyTypeSharesValueFiling
Jul 24, 2026OLMAOpen-market saleCode S · direct12,500$146K@ $11.71Form 4
Jul 23, 2026OLMAOpen-market saleCode S · direct12,500$145K@ $11.58Form 4
Jun 18, 2026OLMAGrant or awardCode A · direct29,500—Form 4
Jan 20, 2026OLMAOpen-market saleCode S · direct10,000$269K@ $26.88Form 4
Jan 14, 2026OLMAOpen-market saleCode S · direct3,489$102K@ $29.12Form 4
Dec 22, 2025OLMAOpen-market saleCode S · direct2,881$82K@ $28.53Form 4

How this page is built

Every row comes from a Form 4 filed with the SEC, which officers, directors and holders of more than 10% of a company’s stock must file within two business days of a trade. Transactions are grouped by the reporting owner’s name as filed (spacing, capitals and punctuation ignored); two different people filing under an identical name would appear together, and one person filing under two spellings appears on two pages.

Open-market totals count code P purchases and code S sales over the last 24 months. The same trade reported on more than one filing is counted once; when another owner (for example a fund and its general partner) reports the identical trade, they are listed beside it. Holdings are the shares owned after the latest purchase, sale, gift or tax-withholding line, shown separately for direct and indirect ownership; an indirect figure is one holding line, not a total across every trust or entity.

This page describes what was filed with the SEC; it is not investment advice or a recommendation to buy or sell any security.